These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6867079)

  • 21. Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: in vitro and in vivo evaluation in healthy volunteers.
    Xu X; Sun M; Zhi F; Hu Y
    Int J Pharm; 2006 Mar; 310(1-2):139-45. PubMed ID: 16413710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioavailability of ciprofloxacin tablets in humans and its correlation with the dissolution rates.
    Khan MK; Khan MF; Khan H; Mustafa G
    Pak J Pharm Sci; 2009 Jul; 22(3):329-34. PubMed ID: 19553184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of modified starches in direct compression of a poorly water soluble drug (hydrochlorothiazide).
    Okafor IS; Ofoefule SI; Udeala OK
    Boll Chim Farm; 2001; 140(1):36-9. PubMed ID: 11338775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on formulation and bioavailability of benorilate tablets].
    Chen J; Tu XD
    Yao Xue Xue Bao; 1994; 29(9):707-12. PubMed ID: 7900541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
    Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
    Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioavailability of doxycycline from dissolved doxycycline hydrochloride tablets--comparison to solid form hydrochloride tablets and dissolved monohydrate tablets.
    Saano V; Paronen P; Peura P
    Int J Clin Pharmacol Ther Toxicol; 1990 Nov; 28(11):471-4. PubMed ID: 2272707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioavailability of different brands of griseofulvin tablets and its correlation to dissolution data.
    Khalafalla N; Elgholmy ZA; Khalil SA
    Pharmazie; 1980 Aug; 35(8):482-4. PubMed ID: 7433499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Optimization of formulation of Fufang Danshen immediate release tablet by colligation score].
    Hu RF; Zhu JB; Peng DY; Tang JH; Zhou A
    Zhongguo Zhong Yao Za Zhi; 2006 Mar; 31(5):380-2. PubMed ID: 16711419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro--in vivo evaluation of tableted caseinchitosan microspheres containing diltiazem hydrochloride.
    al-Suwayeh SA; el-Helw AR; al-Mesned AF; Bayomi MA; el-Gorashi AS
    Boll Chim Farm; 2003; 142(1):14-20. PubMed ID: 12680034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of Albizia zygia gum as a binding agent in tablet formulations.
    Odeku OA
    Acta Pharm; 2005 Sep; 55(3):263-76. PubMed ID: 16375837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo/in vitro correlations for four differently dissolving ketorolac tablets.
    Gordon MS; Chowhan Z
    Biopharm Drug Dispos; 1996 Aug; 17(6):481-92. PubMed ID: 8866039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-vitro and in-vivo correlation of enhancement of dissolution rate of water insoluble drugs.
    al-Meshal MA
    Res Commun Chem Pathol Pharmacol; 1990 Mar; 67(3):415-8. PubMed ID: 2343187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxytetracycline tablet formulations: the effect of wet mixing time, particle size and batch variation on granule and tablet properties.
    Chalmers AA; Elworthy PG
    J Pharm Pharmacol; 1976 Mar; 28(3):239-43. PubMed ID: 6699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Some formulation factors affecting the tensile strength, disintegration and dissolution of uncoated oxytetracycline tablets.
    Esezobo S; Pilpel N
    J Pharm Pharmacol; 1976 Jan; 28(1):8-16. PubMed ID: 6662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the dissolution behaviour of tablets containing the drug in a polyethyleneglycol solid dispersion with direct compressed tablets.
    Kinget R
    Pharm Acta Helv; 1989; 64(3):90-3. PubMed ID: 2726990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioavailability of oxytetracycline dihydrate tablets in dogs.
    Cooke RG; Knifton A; Murdoch DB; Yacoub IS
    J Vet Pharmacol Ther; 1981 Mar; 4(1):11-3. PubMed ID: 7349318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple level C in vitro/in vivo correlation of dissolution profiles of two L-thyroxine tablets with pharmacokinetics data obtained from patients treated for hypothyroidism.
    Volpato NM; Silva RL; Brito AP; Gonçalves JC; Vaisman M; Noël F
    Eur J Pharm Sci; 2004 Apr; 21(5):655-60. PubMed ID: 15066666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tablet disintegration and drug dissolution in viscous media: paracetamol IR tablets.
    Parojcić J; Vasiljević D; Ibrić S; Djurić Z
    Int J Pharm; 2008 May; 355(1-2):93-9. PubMed ID: 18226480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.